← FDA Drug Approvals (Drugs@FDA)
NALOXONE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2025-04-24
Drug application
- FDA Application #
ANDA216719- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- NALOXONE HYDROCHLORIDE
- Generic name
- Naloxone Hydrochloride
- Active ingredients
- NALOXONE HYDROCHLORIDE
- Dosage form
- SPRAY
- Route
- NASAL
- Marketing status
- Discontinued
- Sponsor
- PADAGIS ISRAEL
- First approval
- 2025-04-24
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown